Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabell Sesterhenn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PETSandi A Kwee, Hai Wei, Isabell Sesterhenn, et al.
Journal of Cancer|June 18, 2019
ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese MenJiang Baohong, Jason Sedarsky, Shiv Srivastava, et al.
The American Journal of Surgical Pathology|February 15, 2011
ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinomaMarkku Miettinen, Zeng-Feng Wang, Anders Paetau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablationZhiqiang Zou, Wei Zhang, Denise Young, et al.
Virchows Archiv : an International Journal of Pathology|April 11, 2002
Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International ConsultationAntonio Lopez-Beltran, Liang Cheng, Lennart Andersson, et al.
Molecular Medicine (Cambridge, Mass.)|December 13, 2002
A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumorsMei Sun, Lanfeng Ma, Linda Xu, et al.
Cancer Medicine|January 23, 2020
Race, tumor location, and disease progression among low-risk prostate cancer patientsJustin G Mygatt, Jennifer Cullen, Samantha A Streicher, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
Journal of Pathology Informatics|July 2, 2024
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancerSushant Patkar, Stephanie Harmon, Isabell Sesterhenn, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PETSandi A Kwee, Hai Wei, Isabell Sesterhenn, et al.
Journal of Cancer|June 18, 2019
ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese MenJiang Baohong, Jason Sedarsky, Shiv Srivastava, et al.
The American Journal of Surgical Pathology|February 15, 2011
ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinomaMarkku Miettinen, Zeng-Feng Wang, Anders Paetau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablationZhiqiang Zou, Wei Zhang, Denise Young, et al.
Virchows Archiv : an International Journal of Pathology|April 11, 2002
Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International ConsultationAntonio Lopez-Beltran, Liang Cheng, Lennart Andersson, et al.
Molecular Medicine (Cambridge, Mass.)|December 13, 2002
A human novel gene DERPC on 16q22.1 inhibits prostate tumor cell growth and its expression is decreased in prostate and renal tumorsMei Sun, Lanfeng Ma, Linda Xu, et al.
Cancer Medicine|January 23, 2020
Race, tumor location, and disease progression among low-risk prostate cancer patientsJustin G Mygatt, Jennifer Cullen, Samantha A Streicher, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
Journal of Pathology Informatics|July 2, 2024
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancerSushant Patkar, Stephanie Harmon, Isabell Sesterhenn, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Pageof 2